464 Comprehensive genomic profiling of advanced cancers identifies MET exon 14 alterations that are sensitive to MET inhibitors
Frampton, G., Ali, S., Rosenzweig, M., Chmielecki, J., Bauer, T., Akimov, M., Peters, M., Bufill, J., Lee, C., Ou, I., Salgia, R., Yelensky, R., Morosini, D., Ross, J., Philip, S., Miller, V.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)30298-2
Date:
September, 2015
File:
PDF, 71 KB
english, 2015